Marksans Pharma Limited: Detailed financials
Line items extracted directly from the company's exchange-filed XBRL. Click + to expand subtotals. Click any row to chart it. Monetary values are in ₹ crore.
Company financials
| Particulars | Sep-24 | Dec-24 | Mar-25 | Jun-25 | Sep-25 | Dec-25 | Mar-26 | Jun-26 |
|---|---|---|---|---|---|---|---|---|
| 642 | 682 | 71 | 620 | 720 | 754 | 856 | 841 | |
| 11 | 28 | 2 | 6 | 22 | 20 | 35 | 25 | |
| 528 | 566 | 61 | 549 | 609 | 624 | 691 | 660 | |
| 214 | 189 | 19 | 193 | 228 | 274 | 265 | 221 | |
| 134 | 112 | 16 | 172 | 106 | 27 | 150 | 138 | |
| −90 | −3 | −2 | −102 | −25 | 15 | −24 | −16 | |
| 84 | 88 | 10 | 98 | 104 | 112 | 107 | 114 | |
| 3 | 3 | 0.34 | 6 | 6 | 6 | 6 | 7 | |
| 20 | 21 | 2 | 23 | 27 | 24 | 24 | 25 | |
| 164 | 156 | 16 | 160 | 164 | 165 | 163 | 170 | |
| 147 | 167 | 14 | 106 | 166 | 181 | 231 | 238 | |
| 127 | 146 | 12 | 83 | 139 | 157 | 206 | 214 | |
| 125 | 143 | 12 | 77 | 133 | 151 | 200 | 207 | |
| 27 | 38 | 3 | 18 | 34 | 37 | 51 | 47 | |
| 98 | 105 | 9 | 58 | 99 | 114 | 149 | 159 | |
| Financial ratios | ||||||||
| 22.86% | 24.44% | 20.07% | 17.06% | 23.05% | 23.98% | 26.94% | 28.36% | |
| 15.23% | 15.41% | 12.80% | 9.39% | 13.76% | 15.07% | 17.41% | 18.96% | |
| 2.13 | 2.31 | 2.00 | 1.29 | 2.17 | 2.50 | 3.27 | 3.47 | |
Revenue
₹ crore
Select any table row to compare its reported history.
Source: official NSE or BSE financial-result filings & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Derived margins, subtotals, leverage and cash-flow measures use only the displayed filed line items.